Author | Lynda Charters


Injections offer relief for refractory severe noninfectious keratitis

Joseph Grieco, PhD, notes that treatment fills a gap for patients who are unresponsive to the standard treatments for noninfectious keratitis.

Researchers target ocular blood flow, systemic organ blood flow in hemorrhagic shock

Non-invasive ocular blood flow measurement using laser speckle flowgraphy may be a new indicator of shock-related organ damage, investigators report.

Initial data from AGTC-501 subretinal gene therapy for X-linked RP demonstrates safety, efficacy

During an ARVO presentation, Paul Yang, MD, PhD, explained that in a clinical trial, investigators used an adeno-associated viral vector to deliver a normal functioning copy of the RPGR gene via subretinal injection.

Non-viral gene therapy eases treatment burden in wet AMD

May 03, 2021

EYS809, a non-viral gene therapy sustained drug-delivery product that delivers anti-vascular endothelial growth factor to the eye, may replace the need for repeated intravitreal anti-VEGF injections and improve vision in patients diagnosed with wet age-related macular degeneration.